Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Annals of Surgical Oncology
|
March 8, 2024
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
Thorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 16, 2021
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients
Jan Heil, Franziska Heid, Wolf O Bechstein, et al.
Transplantation
|
March 23, 2017
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M Neuberger, Wolf O Bechstein, Dirk R J Kuypers, et al.
International Journal of Cancer
|
March 8, 2023
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, et al.
JAMA Oncology
|
November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
Transplantation
|
January 27, 2017
Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
Jonas Wadström, Bo-Göran Ericzon, Philip F Halloran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.
Annals of Surgery
|
August 2, 2021
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials
Dominique L Birrer, Henriette Golcher, Riccardo Casadei, et al.
Annals of Surgery
|
September 1, 2018
Toward a Consensus on Centralization in Surgery
René Vonlanthen, Peter Lodge, Jeffrey S Barkun, et al.
Zeitschrift Fur Gastroenterologie
|
September 9, 2024
Thomas Berg, Niklas F Aehling, Tony Bruns, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Annals of Surgical Oncology
|
March 8, 2024
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
Thorsten O Goetze, Alexander Reichart, Ulli S Bankstahl, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 16, 2021
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients
Jan Heil, Franziska Heid, Wolf O Bechstein, et al.
Transplantation
|
March 23, 2017
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M Neuberger, Wolf O Bechstein, Dirk R J Kuypers, et al.
International Journal of Cancer
|
March 8, 2023
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, et al.
JAMA Oncology
|
November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
Transplantation
|
January 27, 2017
Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
Jonas Wadström, Bo-Göran Ericzon, Philip F Halloran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.
Annals of Surgery
|
August 2, 2021
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials
Dominique L Birrer, Henriette Golcher, Riccardo Casadei, et al.
Annals of Surgery
|
September 1, 2018
Toward a Consensus on Centralization in Surgery
René Vonlanthen, Peter Lodge, Jeffrey S Barkun, et al.
Zeitschrift Fur Gastroenterologie
|
September 9, 2024
Thomas Berg, Niklas F Aehling, Tony Bruns, et al.
Page
of 15